Clinical Trial Update: Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of intranasal insulin on neuroimaging markers and cognition in patients with psychotic disorders; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Mclean Hospital | Conditions: Psychosis, Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2025-04-15